Benefit-risk assessment to support the FDA's decision on vaccines for SARS-CoV-2

被引:0
|
作者
Yang, Hong [1 ]
机构
[1] FDA, CBER, OBPV, Silver Spring, MD USA
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
243
引用
收藏
页码:103 / 103
页数:1
相关论文
共 50 条
  • [1] Benefit-risk assessment of vaccines
    Kochhar, Sonali
    Izurieta, Hector S.
    Chandler, Rebecca E.
    Hacker, Adam
    Chen, Robert T.
    Levitan, Bennett
    VACCINE, 2024, 42 (04) : 969 - 971
  • [2] Balancing risk and benefit of SARS-CoV-2 vaccines in children Comment
    Levin, Michael
    Whittaker, Elizabeth
    LANCET REGIONAL HEALTH-EUROPE, 2022, 18
  • [3] Antirheumatic in SARS-CoV-2: benefit or risk?
    Ferrara, Francesco
    ITALIAN JOURNAL OF MEDICINE, 2020, 14 (02) : 114 - 115
  • [4] SARS-CoV-2 Vaccines
    Creech, C. Buddy
    Walker, Shannon C.
    Samuels, Robert J.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (13): : 1318 - 1320
  • [5] FDA's Benefit-Risk Framework for Human Drugs and Biologics: Role in Benefit-Risk Assessment and Analysis of Use for Drug Approvals
    Lackey, Leila
    Thompson, Graham
    Eggers, Sara
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2021, 55 (01) : 170 - 179
  • [6] Bell's palsy and SARS-CoV-2 vaccines
    Ozonoff, Al
    Nanishi, Etsuro
    Levy, Ofer
    LANCET INFECTIOUS DISEASES, 2021, 21 (04): : 450 - 452
  • [7] Environmental Risk Assessment of Recombinant Viral Vector Vaccines against SARS-Cov-2
    Baldo, Aline
    Leunda, Amaya
    Willemarck, Nicolas
    Pauwels, Katia
    VACCINES, 2021, 9 (05)
  • [8] Platform-Specific Risk Assessment of SARS-CoV-2 Vaccines Using FMEA
    Jindani, Rajika
    Sheth, Smritie
    Paul, Soumya
    Rathore, Anurag
    Chirmule, Narendra
    BIOPHARM INTERNATIONAL, 2021, 34 (02) : 15 - 20
  • [9] SARS-CoV-2 vaccines in development
    Krammer, Florian
    NATURE, 2020, 586 (7830) : 516 - 527
  • [10] SARS-CoV-2 vaccines and myocarditis
    Sularz, Agata Katarzyna
    Hua, Alina
    Ismail, Tevfik
    CLINICAL MEDICINE, 2023, 23 (05) : 495 - 502